RecruitingPhase 3ACTRN12612000517875

Hypotension in Threatened Preterm Labour Treating with Initial Loading Dose of 30 mg versus 40 mg Nifedipine


Sponsor

Khon Kaen Hospital

Enrollment

90 participants

Start Date

May 1, 2012

Study Type

Interventional

Conditions

Summary

Preterm birth significantly contributes to infant morbidities and neurological disability. It has been hope that tocolytic treatment would reduce the consequences of preterm birth by prolonging pregnancy Calcium channel blockers (CCB) have been used to prevent preterm labor over 20 years. Nifedipine is the first CCB used for tocolytics therapy by 1980 Although nifedipine has significantly lower of maternal and fetal side-effects than alternatives, but the major concern is about vasodilating properties which can induce maternal tachycardia, headache, nausea, hot flush, palpitation and especially severe hypotension Suchaya 2010 study in 157 Thai women 17% of cases experienced hypotension within 60 min after receiving nifedipine. Of these there was no severe hypotension. But if the pregnant women had lower baseline, profound shock can be occurred (Before using nifedipine, the mean systolic and diastolic blood pressures were 109.4 +/- 10.4 and 72.5 +/- 7.9 mmHg the mean decrease of systolic and diastolic blood pressure in severe hypotension was 16.3 and 14.5 mmHg) The incidence of profound hypotension(BP<90/60 mmHg) at first 60 minutes is 3.8% From previous study show that there was same effectiveness of using oral nifedipine 30 mg between 40 mg loading in the first hour for tocolysis .In Suchaya 2010 trial was study in Thai pregnant woman show incidence of hypotension was 17% when treated preterm labour with initial loading dose 40 mg . We aim that decreasing the incidence of hypotension could be reached by lowering the initial nifedipine loading dose


Eligibility

Sex: FemalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is comparing two starting doses of nifedipine, a medication used to stop preterm labor (when a baby is coming too early). Nifedipine relaxes the uterus but can cause a dangerous drop in blood pressure. Researchers want to find out if a lower starting dose of 30 mg causes less hypotension than the standard 40 mg dose, while still being effective at slowing or stopping contractions. You may be eligible if: - You are a pregnant woman aged 18 or older - Your pregnancy is between 24 and 36 weeks - You are experiencing uterine contractions (at least one per 10 minutes) - Your cervix is dilated 3 cm or less You may NOT be eligible if: - You have active medical conditions such as heart disease, kidney disease, diabetes, or thyroid disease - You have an infection in the womb (chorioamnionitis), placental abruption, ruptured membranes, or severe preeclampsia - You have a condition that prevents you from taking oral medication Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Arm 1: nifedipine 30 mg loading in 1 hour (10 mg orally every 20 minutes) then nifedipine slow release (SR) 20 mg orally every 4-8 hours until 48 hours, regularly of treatment given will be at the dis

Arm 1: nifedipine 30 mg loading in 1 hour (10 mg orally every 20 minutes) then nifedipine slow release (SR) 20 mg orally every 4-8 hours until 48 hours, regularly of treatment given will be at the discretion of the treating physician


Locations(1)

Khon Kaen, Thailand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000517875